INTRODUCTION OF NEW DEVICES MEDICAL DEVICE VITROCARE (Q4149788): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in es, and other parts: Adding Spanish translations) |
(Changed label, description and/or aliases in en, and other parts: Adding English translations) |
||||||||||||||
| label / en | label / en | ||||||||||||||
INTRODUCTION OF NEW DEVICES MEDICAL DEVICE VITROCARE | |||||||||||||||
| Property / summary | |||||||||||||||
IN 2016, THE OPPORTUNITY TO DEVOTE COMMERCIAL ATTENTION TO THE PRODUCTION OF PARTICULAR INTRAOCULAR DYES USED IN THE COURSE OF OPHTHALMIC RETINAL VITREOUS SURGERY, TO HIGHLIGHT PATHOGENIC MICROOCULAR STRUCTURES ON WHICH THE OPERATOR MUST WORK, FOR THE SPECIALIST OPHTHALMIC MEDICAL SECTOR, HAS BEEN SEEN. THE NEW PRODUCTION LINE ALREADY ESTABLISHED AT NATIONAL LEVEL AND IN EUROPE WITH SEVERAL SCIENTIFIC PUBLICATIONS HAS BEEN CALLED “VITREOCARE” THIS LINE IS THE SUBJECT OF THE INVESTMENT PROGRAMME. IN RECENT YEARS THERE IS A GLIMPSE, IN FACT, THE OPPORTUNITY OF A GREATER PENETRATION IN THE MARKETS OF SOME OPHTHALMIC PRODUCTS, IN PARTICULAR WITH THE PRODUCTION OF MEDICAL DEVICE FOR RETINAL BUFFERING IN SURGERY OF THE BACK OCULAR SEGMENT WITH OILS OF THIRD GENERATION ULTRA PURIFIED LIGHT AND HEAVY PARTICULARLY INDICATED IN THE PATHOLOGIES OF THE SUPERIOR RETINAL DETACHMENT AND INFERIORE.SI Ê DECIDED TO DEVELOP (English) | |||||||||||||||
| Property / summary: IN 2016, THE OPPORTUNITY TO DEVOTE COMMERCIAL ATTENTION TO THE PRODUCTION OF PARTICULAR INTRAOCULAR DYES USED IN THE COURSE OF OPHTHALMIC RETINAL VITREOUS SURGERY, TO HIGHLIGHT PATHOGENIC MICROOCULAR STRUCTURES ON WHICH THE OPERATOR MUST WORK, FOR THE SPECIALIST OPHTHALMIC MEDICAL SECTOR, HAS BEEN SEEN. THE NEW PRODUCTION LINE ALREADY ESTABLISHED AT NATIONAL LEVEL AND IN EUROPE WITH SEVERAL SCIENTIFIC PUBLICATIONS HAS BEEN CALLED “VITREOCARE” THIS LINE IS THE SUBJECT OF THE INVESTMENT PROGRAMME. IN RECENT YEARS THERE IS A GLIMPSE, IN FACT, THE OPPORTUNITY OF A GREATER PENETRATION IN THE MARKETS OF SOME OPHTHALMIC PRODUCTS, IN PARTICULAR WITH THE PRODUCTION OF MEDICAL DEVICE FOR RETINAL BUFFERING IN SURGERY OF THE BACK OCULAR SEGMENT WITH OILS OF THIRD GENERATION ULTRA PURIFIED LIGHT AND HEAVY PARTICULARLY INDICATED IN THE PATHOLOGIES OF THE SUPERIOR RETINAL DETACHMENT AND INFERIORE.SI Ê DECIDED TO DEVELOP (English) / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / summary: IN 2016, THE OPPORTUNITY TO DEVOTE COMMERCIAL ATTENTION TO THE PRODUCTION OF PARTICULAR INTRAOCULAR DYES USED IN THE COURSE OF OPHTHALMIC RETINAL VITREOUS SURGERY, TO HIGHLIGHT PATHOGENIC MICROOCULAR STRUCTURES ON WHICH THE OPERATOR MUST WORK, FOR THE SPECIALIST OPHTHALMIC MEDICAL SECTOR, HAS BEEN SEEN. THE NEW PRODUCTION LINE ALREADY ESTABLISHED AT NATIONAL LEVEL AND IN EUROPE WITH SEVERAL SCIENTIFIC PUBLICATIONS HAS BEEN CALLED “VITREOCARE” THIS LINE IS THE SUBJECT OF THE INVESTMENT PROGRAMME. IN RECENT YEARS THERE IS A GLIMPSE, IN FACT, THE OPPORTUNITY OF A GREATER PENETRATION IN THE MARKETS OF SOME OPHTHALMIC PRODUCTS, IN PARTICULAR WITH THE PRODUCTION OF MEDICAL DEVICE FOR RETINAL BUFFERING IN SURGERY OF THE BACK OCULAR SEGMENT WITH OILS OF THIRD GENERATION ULTRA PURIFIED LIGHT AND HEAVY PARTICULARLY INDICATED IN THE PATHOLOGIES OF THE SUPERIOR RETINAL DETACHMENT AND INFERIORE.SI Ê DECIDED TO DEVELOP (English) / qualifier | |||||||||||||||
point in time: 31 January 2022
| |||||||||||||||
Revision as of 11:06, 31 January 2022
Project Q4149788 in Italy
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | INTRODUCTION OF NEW DEVICES MEDICAL DEVICE VITROCARE |
Project Q4149788 in Italy |
Statements
1,337,180.27 Euro
0 references
860,323.21 Euro
0 references
155.43 percent
0 references
ALFA IN-STRUMENTS S.R.L.
0 references
NEL 2016 SI E¿ INTRAVISTA L¿OPPORTUNITà DI DEDICARE L¿ATTENZIONE COMMERCIALE ALLA PRODUZIONE DI PARTICOLARI COLORANTI INTRAOCULARI UTILIZZATI NEL CORSO DI INTERVENTI DI CHIRURGIA VITREO RETINICA OFTALMICA, PER METTERE IN EVIDENZA MICRO STRUTTURE INTRAOCULARI PATOGENE SULLE QUALI L'OPERATORE DEVE LAVORARE, PER IL SETTORE MEDICO SPECIALISTICO OFTALMICO.. LA NUOVA LINEA DI PRODUZIONE GIà AFFERMATA A LIVELLO NAZIONALE ED IN EUROPA CON DIVERSE PUBBLICAZIONI SCIENTIFICHE E¿ STATA DENOMINATA ¿VITREOCARE¿ TALE LINEA Ê OGGETTO DEL PROGRAMMA DI INVESTIMENTO. NEGLI ULTIMI ANNI SI Ê INTRAVISTA, INFATTI, L¿OPPORTUNITà DI UNA MAGGIORE PENETRAZIONE NEI MERCATI DI ALCUNI PRODOTTI OFTALMICI, IN PARTICOLARE CON LA PRODUZIONE DI MEDICAL DEVICE PER IL TAMPONAMENTO RETINICO IN CHIRURGIA DEL SEGMENTO POSTERIORE OCULARE CON OLII DI TERZA GENERAZIONE ULTRA PURIFICATI LEGGERI E PESANTI PARTICOLARMENTE INDICATI NELLE PATOLOGIE DEL DISTACCO RETINICO SUPERIORE ED INFERIORE.SI Ê DECISO DI SVILUPPA (Italian)
0 references
EN 2016, SE HA VISTO LA OPORTUNIDAD DE DEDICAR ATENCIÓN COMERCIAL A LA PRODUCCIÓN DE COLORANTES INTRAOCULARES PARTICULARES UTILIZADOS EN EL CURSO DE LA CIRUGÍA VÍTREA RETINA OFTÁLMICA, PARA DESTACAR ESTRUCTURAS PATÓGENAS MICROOCULAR EN LAS QUE EL OPERADOR DEBE TRABAJAR, PARA EL SECTOR MÉDICO OFTÁLMICO ESPECIALIZADO. LA NUEVA LÍNEA DE PRODUCCIÓN YA ESTABLECIDA A NIVEL NACIONAL Y EN EUROPA CON VARIAS PUBLICACIONES CIENTÍFICAS SE HA DENOMINADO «VITREOCARE», ESTA LÍNEA ES OBJETO DEL PROGRAMA DE INVERSIONES. EN LOS ÚLTIMOS AÑOS SE VISLUMBRA, DE HECHO, LA OPORTUNIDAD DE UNA MAYOR PENETRACIÓN EN LOS MERCADOS DE ALGUNOS PRODUCTOS OFTÁLMICOS, EN PARTICULAR CON LA PRODUCCIÓN DE DISPOSITIVO MÉDICO PARA AMORTIGUACIÓN RETINIANA EN CIRUGÍA DEL SEGMENTO OCULAR DE ESPALDA CON ACEITES DE TERCERA GENERACIÓN ULTRA PURIFICADOS LIGEROS Y PESADOS PARTICULARMENTE INDICADOS EN LAS PATOLOGÍAS DEL DESPRENDIMIENTO SUPERIOR DE LA RETINA E INFERIORE.SI Ê DECIDIÓ DESARROLLAR (Spanish)
30 January 2022
0 references
IN 2016, THE OPPORTUNITY TO DEVOTE COMMERCIAL ATTENTION TO THE PRODUCTION OF PARTICULAR INTRAOCULAR DYES USED IN THE COURSE OF OPHTHALMIC RETINAL VITREOUS SURGERY, TO HIGHLIGHT PATHOGENIC MICROOCULAR STRUCTURES ON WHICH THE OPERATOR MUST WORK, FOR THE SPECIALIST OPHTHALMIC MEDICAL SECTOR, HAS BEEN SEEN. THE NEW PRODUCTION LINE ALREADY ESTABLISHED AT NATIONAL LEVEL AND IN EUROPE WITH SEVERAL SCIENTIFIC PUBLICATIONS HAS BEEN CALLED “VITREOCARE” THIS LINE IS THE SUBJECT OF THE INVESTMENT PROGRAMME. IN RECENT YEARS THERE IS A GLIMPSE, IN FACT, THE OPPORTUNITY OF A GREATER PENETRATION IN THE MARKETS OF SOME OPHTHALMIC PRODUCTS, IN PARTICULAR WITH THE PRODUCTION OF MEDICAL DEVICE FOR RETINAL BUFFERING IN SURGERY OF THE BACK OCULAR SEGMENT WITH OILS OF THIRD GENERATION ULTRA PURIFIED LIGHT AND HEAVY PARTICULARLY INDICATED IN THE PATHOLOGIES OF THE SUPERIOR RETINAL DETACHMENT AND INFERIORE.SI Ê DECIDED TO DEVELOP (English)
31 January 2022
0 references
CASTELLABATE
0 references